by editor | Jun 21, 2023 | Clinicians, Participants, Researchers
Low-dose aspirin may increase anemia risk in healthy older adults: study A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anemia by 20% in some older adults, mostly aged over 70 years (65...
by Trisha | Apr 28, 2022 | Clinicians, Participants, Researchers
U.S. medical expert group latest to cite ASPREE results in guidelines Major findings from the ASPREE trial have been adopted into influential US Preventive Services Taskforce (USPSTF) new medical aspirin guidelines. The USPSTF recently announced a new recommendation...
by admin | Sep 13, 2020 | Clinicians, Participants, Researchers
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the ASPREE trial provides doctors, for the first time, with information about how much aspirin may increase the risk of gastrointestinal (GI) bleeding in...
by editor | Sep 17, 2018 | Clinicians, Participants, Researchers
Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people For decades, doctors have been prescribing low-dose aspirin for healthy people over the age of 70. from shutterstock.com John McNeil, Monash University Taking low-dose aspirin daily...
Recent Comments